Treatment conditions | Estrogenic activity (ng/L E2-EQ) | Androgenic activity (ng/L DHT-EQ) | Glucocorticoid activity (ng/L Dex-EQ) | |
Campaign (TOD mg O3/L) | Sample name |
|
|
|
1 | MBBR | 3 | | 250 |
1 (15) | MBBRO3 tert | | | |
2 | CAS | 5 | | 509 |
2 (5) | CASO3 tert | 1 | | 310 |
2 (9.4) | CASO3 loop | 3 | | 701 |